These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3283655)

  • 1. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
    Untawale S; Blick M
    Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors.
    Melhem MF; Meisler AI; Finley GG; Bryce WH; Jones MO; Tribby II; Pipas JM; Koski RA
    Cancer Res; 1992 Nov; 52(21):5853-64. PubMed ID: 1394214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.
    Ramsay RG; Thompson MA; Hayman JA; Reid G; Gonda TJ; Whitehead RH
    Cell Growth Differ; 1992 Oct; 3(10):723-30. PubMed ID: 1445802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
    Gai XX; Rizzo MG; Valpreda S; Baserga R
    Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the myc gene family in different stages of human colorectal cancer.
    Finley GG; Schulz NT; Hill SA; Geiser JR; Pipas JM; Meisler AI
    Oncogene; 1989 Aug; 4(8):963-71. PubMed ID: 2668847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
    Pape KA; Floyd-Smith G
    Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
    Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survival.
    Erisman MD; Litwin S; Keidan RD; Comis RL; Astrin SM
    Cancer Res; 1988 Mar; 48(5):1350-5. PubMed ID: 3342413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.